Table 3 |
||
|
Therapy for persistent Lyme arthritis refractory to the first antibiotic treatment |
||
|
Persistent Lyme arthritis |
||
|
|
||
|
Antibiotic-refractory persistent arthritis |
Significant inflammation (effusion, limited range of motion, oligoarthritis) |
Repeat |
|
• Intravenous cefotaxime 50 mg/kg/day in one dose (maximum dose 2,000 mg/day) |
||
|
• Intravenous cefotaxime 200 mg/kg/day in three divided doses (maximum dose 6,000 mg/day) |
||
|
• Intravenous penicillin G 0.5 million U/kg/day in four to six divided doses (maximum 20 million U/day) |
||
|
for 14 days up to 28 days |
||
|
Limited inflammation (for example, monoarthritis) |
• Doxycycline 4 mg/kg/day in two divided doses (maximum 200 mg/day; after 8 years of age) |
|
|
for 28 days |
||
|
Additional anti-inflammatory therapy: nonsteroidal anti-inflammatory drugs |
||
|
No remission reached |
In synovial fluid or synovia: |
Prolong antibiotic oral treatment for another month |
|
B. burgdorferi DNA present |
Consider |
|
|
• Intra-articular steroid injection |
||
|
• Disease-modifying antirheumatic drug therapy |
||
|
• Arthroscopic synovectomy |
||
|
B. burgdorferi DNA not present |
Consider |
|
|
• Intra-articular steroid injection |
||
|
• Disease-modifying antirheumatic drug therapy |
||
|
• Arthroscopic synovectomy |
||
|
|
||
|
Girschick et al. Arthritis Research & Therapy 2009 11:258 doi:10.1186/ar2853 |
||